Biotech entity

TRISO fuel

Technology

pharma is the sole category represented across all 1 tracked stories. TRISO fuel is most often covered alongside BWXT, which appears in 1 of these 1 story. We currently track 1 Biotech story that mention TRISO fuel, all published on February 24, 2026.

Last mentioned: Feb 24, 2026

Entity pulse

Recent coverage · TRISO fuel

1 story
6 avg impact
100% positive
0% negative

Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.

  • 100% positive

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about TRISO fuel

pharma is the sole category represented across all 1 tracked stories. TRISO fuel is most often covered alongside BWXT, which appears in 1 of these 1 story. We currently track 1 Biotech story that mention TRISO fuel, all published on February 24, 2026. Each carries 2 original sources on average.

Stories tracked
1
Sources per story
2

Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 18 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering TRISO fuel. Shared-story counts are live from our verified record — not editorial picks.

Timeline

  1. Earnings Release

    Both companies report record Q4 results exceeding analyst guidance on revenue and EBITDA.

  2. Debt Refinancing

    BWXT completes $1.25B convertible debt raise to improve capital structure for 2026 expansion.

  3. Fiscal Year End

    BWXT Medical crosses $100M revenue threshold; Kratos hits record $1.57B backlog.

Stories mentioning TRISO fuel 1

Pharma Positive

BWXT Medical Hits $100M Milestone as Radiopharmaceutical Demand Surges

BWXT Technologies reported record Q4 2025 results, highlighted by its medical segment surpassing the $100 million revenue threshold amid a global expansion in nuclear medicine. The company's strategic pivot toward radiopharmaceuticals, supported by a $1.25 billion debt refinancing, positions it as a critical infrastructure provider for the next generation of targeted cancer therapies.

2 sources

TRISO fuel is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.

See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.